Year: 2026

– Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population, dosing regimen, and treatment duration – – FDA agrees on UMSARS Part I as primary endpoint after ATH434 demonstrated 48% slowing of disease progression versus placebo in Phase 2 study – – FDA agrees with 50mg dose level which achieved clinically and statistically significant efficacy in Phase 2 study – – Pivotal Phase 3 trial activities on track to initiate by year-end 2026 – MELBOURNE, Australia and SAN FRANCISCO, June 09, 2026 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, trading under the ASX code ATHDA until 12 June; NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the successful...

LIBERTY clinical trial will evaluate the comparative safety and tolerability of VYD2311 versus mRNA COVID-19 vaccine, as well as explore the safety and immunology of co-administered VYD2311 and mRNA COVID-19 vaccine Depending on study recruitment rate, Invivyd expects to report topline data from LIBERTY in Q3 2026, to accompany anticipated data from the pivotal DECLARATION clinical trial Prior exploration of monoclonal antibody (mAb) interaction with vaccine published here suggests a minimal clinical consequence to a similar interaction today, but could provide data to aid in potential product labelling language, if approved. This earlier work demonstrated an expected, modest reduction in vaccine-induced neutralizing antibody titers from co-administration of mAb and vaccine, in seronegative populations, with T Cell and other vaccine-induced...

TORONTO, June 09, 2026 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) is pleased to announce it has engaged a team of technical consultants to lead the next phase of development for its Eau Claire Gold Project (“Eau Claire” the “Project), located in the Eeyou-Istchee/James Bay region of northern Quebec. This engagement marks the start of the Company’s pre-feasibility study (“PFS”) work to be completed in accordance with National Instrument 43-101 standards. The PFS is the continuation of the preliminary economic assessment study issued in 2025 (see news release dated September 2, 2025). The Company has retained the services of SGS Geological Services (“SGS”), recognized for its global expertise in geological modeling and resource estimation and BBA Consultants (“BBA”), a top Canadian...

COPENHAGEN, Denmark, June 9, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a government contract valued over DKK 700 million to supply its MVA-BN® smallpox/mpox vaccine to an undisclosed country in 2026 and 2027. Paul Chaplin, President & CEO of Bavarian Nordic, said: “We are pleased to expand our commitment to supporting governments in their efforts to protect populations against mpox and smallpox. MVA-BN remains a critical tool for both outbreak response and long-term stockpiling. Ensuring reliable access to medical countermeasures requires sustained investment in preparedness, strategic stockpiles and manufacturing capabilities that can be mobilized when needed. Through continued regulatory expansion and manufacturing scale-up, Bavarian Nordic is helping to strengthen public health resilience and readiness...

Utrecht, 9 June 2026 Aalberts today reports that it has repurchased none of its own shares in the period from 01 June 2026, up and including 05 June 2026. This is part of the share buyback programme as announced on 26 February 2026, for a total amount of EUR 75 million. The repurchase of shares commenced on 27 February 2026 and will be completed no later than 9 October 2026. It is intended that the shares will be cancelled following repurchase. Up to and including 05 June 2026, a cumulative total of 1,148,011 shares was repurchased under the share buyback programme for a total consideration of EUR 35,957,577. Aalberts has engaged an intermediary to repurchase the Aalberts shares in the open market, during open and closed periods, independent of Aalberts. The share buyback will be executed within the limitations of the authority granted...

Aktsiaselts Infortar acquired on June 5, 2026, an additional 1,709,937 shares of AS Tallink Grupp (hereinafter referred to as Tallink) shares. The price per Tallink share was €0.648.The Tallink announcement can be found here. Infortar operates in seven countries. the company’s main fields of activity are maritime transport, energy and real estate. Infortar owns a 68.76% share in Tallink Grupp, a 100% share in Elenger Grupp and a versatile and modern real estate portfolio of approx. 141.000 m2. In addition to the three main areas of activity Infortar also operates in agriculture, engineering, construction minerals, printing sector, services and other areas. A total of 107 companies belong to the Infortar group, including 3 affiliated companies and 2 subsidiaries of affiliated companies. Excluding affiliates Infortar employs 6288 people. Additional...

HOUSTON, June 09, 2026 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) announced today that its Mission Technology Solutions business has been awarded the $95 million Digital Engineering and Enterprise Decision Support (DEEDS) contract. The new cost-plus-fixed-fee (CPFF) contract will rapidly advance digital engineering capabilities for the U.S. Space Force, driving the development of space systems and space warfighting technologies. KBR will enable faster, analytics-driven technology and acquisition decisions over a five-year period of performance. The award reflects KBR’s ability to quickly understand evolving mission requirements and provide strategically aligned solutions at speed and scale. KBR will accelerate the transition of next-generation space capabilities from concept to operational deployment, strengthening mission readiness in...

New intercepts located in Southern Expansion Area MONTREAL, June 09, 2026 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals“) (TSX: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce initial results from the 2026 drill program at the Gaspé Copper Project, located in the Gaspé Peninsula of Eastern Québec. Five drills are currently active on the property, with two additional drills commencing work this month. New analytical results from the 2026 drill program are presented below (see Table 1), including four mineralized intercepts from two new drill holes. For the 2026 program, reported “infill” intercepts will be located within the 2026 MRE model (see April 14, 2026 news release), and will be focused on upgrading inferred mineral resources to measured or indicated categories,...